Modern diagnostic capabilities of neonatal screening for primary immunodeficiencies in newborns
Authors:
- Evgenia Olegovna KhalturinaEKEvgenia Olegovna Khalturina
- Natalia Dmitrievna DegtyarevaNDNatalia Dmitrievna Degtyareva
- Anastasiia Vasi’eVna BairashevskaiaABAnastasiia Vasi’eVna Bairashevskaia
- Alena Valerievna MulenkovaAMAlena Valerievna Mulenkova
- Anna Vladimirovna DegtyarevaADAnna Vladimirovna Degtyareva
Open Access
- 15 October 2021
- journal article
- review article
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 64 (10) , 504-510
Abstract
Population screening of newborns is an extremely important and informative diagnostic approach that allows early identification of babies who are predisposed to the development of a number of serious diseases. Some of these diseases are known and have effective treatment methods. Neonatal screening enables the early diagnosis and subsequent timely initiation of therapy. This helps to prevent serious complications and reduce the percentage of disability and deaths among newborns and young children. Primary immunodeficiency diseases and primary immunodeficiency syndrome (PIDS) are a heterogeneous group of diseases and conditions based on impaired immune system function associated with developmental defects and characterized by various combinations of recurrent infections, development of autoimmune and lymphoproliferative syndromes (genetic defects in apoptosis, gene mutation Fas receptor or ligand), granulomatous process, and malignant neoplasms. Most of these diseases manifest in infancy and lead to serious illness, disability, and high mortality rates. Until recently, it was impossible to identify children with PIDS before the onset of the first clinical symptoms, which are usually accompanied by complications in the form of severe coinfections of a viral-bacterial-fungal etiology. Modern advances in medical laboratory technology have allowed the identification of children with severe PIDS, manifested by T- and/or B-cell lymphopenia and other disorders of the immune system. This review discusses the main existing strategies and directions used in PIDS screening programs for newborns, including approaches to screening based on excision of T-cell receptors and kappa-recombination excision circles, as well as the potential role and place of next-generation sequencing technology to increase the diagnostic accuracy of these diseases.Keywords
This publication has 47 references indexed in Scilit:
- Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficienciesCurrent Opinion in Allergy and Clinical Immunology, 2012
- The long quest for neonatal screening for severe combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2012
- Newborn screening for primary immunodeficiencies: beyond SCID and XLAAnnals of the New York Academy of Sciences, 2011
- The case for newborn screening for severe combined immunodeficiency and related disordersAnnals of the New York Academy of Sciences, 2011
- A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID)Molecular Genetics and Metabolism, 2011
- What can exome sequencing do for you?Journal of Medical Genetics, 2011
- Next-Generation Sequencing Techniques for Eukaryotic Microorganisms: Sequencing-Based Solutions to Biological ProblemsEukaryotic Cell, 2010
- Sequencing technologies — the next generationNature Reviews Genetics, 2009
- Mutation analysis in primary immunodeficiency diseases: case studiesCurrent Opinion in Allergy and Clinical Immunology, 2009
- Determination of thymic function directly from peripheral blood: A validated modification to an established methodJournal of Immunological Methods, 2008